FDA Inspection
Michael P. Husseman, MDMichael P. Husseman, MD – FDA Inspection, Feb 16, 2010
Record Details
This FDA Inspection record concerns Michael P. Husseman, MD, with an inspection on February 16, 2010, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Michael P. Husseman, MD
- Inspection Date
- February 16, 2010
- Product Type
- Biologics
View Company Profile
ID · a92b8920-6efb-4db1-a332-5c161f6de193
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 644316
- FDA center
- Biologics
- Project area
- Bioresearch Monitoring
FDA Citations
3- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
- 21 CFR 312.62(a)Accountability records
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Michael P. Husseman, MD
2| Date | Classification | Office | Project area |
|---|---|---|---|
| February 18, 2022 | NAI | Center for Biologics Evaluation and Research | Bioresearch Monitoring |
| December 23, 2014 | VAI | Center for Biologics Evaluation and Research | Bioresearch Monitoring |
Other documents for Michael P. Husseman, MD
- FDA Inspection 1164828 - 2022-02-18
- FDA Inspection 910840 - 2014-12-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.